(19)
(11)
EP 1 482 946 A1
(12)
(43)
Date of publication:
08.12.2004
Bulletin 2004/50
(21)
Application number:
02707980.5
(22)
Date of filing:
14.03.2002
(51)
International Patent Classification (IPC)
7
:
A61K
31/565
,
A61K
31/57
(86)
International application number:
PCT/US2002/007562
(87)
International publication number:
WO 2003/077923
(
25.09.2003
Gazette 2003/39)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI
(71)
Applicant:
Watson Pharmaceuticals, Inc.
Corona, CA 92880 (US)
(72)
Inventor:
TAN, Domingo, Y.
Irvine, CA 92620 (US)
(74)
Representative:
Thomson, Paul Anthony
Potts, Kerr & Co.15, Hamilton Square
BirkenheadMerseyside CH41 6BR
BirkenheadMerseyside CH41 6BR (GB)
(54)
PROGESTERONE ORAL DRUG DELIVERY SYSTEM